Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20??g and Drospirenone 3mg (Q61896522)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Efficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20microg and drospirenone 3mg (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

U Karck

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

H G Weidenhammer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

J Kunz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

S Alincic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

J Marr

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

143-150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel

23 December 2019

cites work

1 reference

12 December 2020

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study

1 reference

12 December 2020

A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).

1 reference

12 December 2020

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle co

1 reference

12 December 2020

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone

1 reference

12 December 2020

Yasmin: the reason why.

1 reference

12 December 2020

A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene

1 reference

12 December 2020

The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea

1 reference

12 December 2020

A multicenter, randomized study of an extended cycle oral contraceptive

1 reference

12 December 2020

Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment

1 reference

12 December 2020

Unintended pregnancies and use, misuse and discontinuation of oral contraceptives

1 reference

12 December 2020

The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential

1 reference

12 December 2020

Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons

1 reference

12 December 2020

An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen

1 reference

12 December 2020

An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group

1 reference

12 December 2020

Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol

1 reference

12 December 2020

Recommendation for confidence interval and sample size calculation for the Pearl Index

1 reference

12 December 2020

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestre

1 reference

12 December 2020

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle contr

1 reference

12 December 2020

A randomized double-blind trial of two low dose combined oral contraceptives

1 reference

12 December 2020

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.

1 reference

12 December 2020

Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).

1 reference

12 December 2020

10.2165/00044011-200626030-00004

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17163245%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference